SJ-ELiOT: St Jude - Phase 1 Evaluation of LY2606368, Molecularly-Targeted CHK1/2i Therapy, in Combination with Cyclophosphamide or Gemcitabine for Children and Adolescents with Refractory or Recurrent Medulloblastoma Brain Tumours
GA ID:
Agency:
Department of Health and Aged Care
Publish Date:
26-Apr-2019
Category:
Medical Research
Grant Term:
1-Apr-2019
to
31-Mar-2024
Value (AUD):
$226,283.60
Recipient Name:
Monash University
Last Updated:
26-Apr-2019 3:49 pm (ACT Local Time)